Biologic Market Slips as Biosimilars Come to the Fore

By: Tuesday December 20, 2011 8:55 am

During the health care debate, this website focused on the biologics provisions in the law. Because of the influence of biotechnology companies, lawmakers pushed for an exemption of 12 years for the expensive drugs, during which time no generics could enter the market. In the final negotiations that got lowered to 10 years. In some [...]

PhRMA Threatening Opposition To Health Care Bill Over Two-Year Drop In Biologics Exclusion

By: Friday January 15, 2010 3:02 pm

As I noted earlier, the President used his closed-door meeting with the House Democratic caucus yesterday to announce his support for dropping the exclusivity period for biologic drugs by at least two years. A source familiar with the meeting, whose professional position does not allow public communication with the press, told me that Anna Eshoo, [...]

Obama Pushing Lower Biologics Protection In Health Care Bill

By: Friday January 15, 2010 7:00 am

The President is clearly taking control of health care reform. We know about the pep talk Obama gave publicly in his meeting with House Democrats, but it was the private session that revealed much more. Clearly, Obama was leaning on the House caucus to pass through health care. But there were a couple specifics that [...]

Loophole Adds Annual Limits on Insurance Coverage For High-Cost Illnesses In Senate Bill

By: Friday December 11, 2009 8:18 am

Today’s report that the Senate health care bill includes a loophole which would place an annual cap on medical care for expensive illnesses like cancer violates President Obama’s core principles for health reform. In the Obama plan released as part of his address to a joint session of Congress, the President clearly states that there [...]

Genentech Plants Talking Points In The Mouths Of 42 Politicians During Health Care Debate

By: Monday November 16, 2009 7:34 am

Over the weekend, The New York Times broke one of the most important stories of the year – one that clarifies the close relationship between politicians and lobbyists. In the official record of the historic House debate on overhauling health care, the speeches of many lawmakers echo with similarities. Often, that was no accident. Statements [...]

The Windfall For The Pharmaceutical Industry In Health Care Reform

By: Wednesday November 11, 2009 2:54 pm

Last night, Jon Cohn reported on damning evidence that the pharmaceutical industry would stand to gain prohibitively from the health care bills passing through Congress. Despite a pledge of giving back $80 billion in profits over ten years as part of a celebrated “deal” between PhRMa and the White House, health reform wouldn’t cut into [...]

Marcy Winograd Takes On Jane Harman Over Biologics

By: Friday November 6, 2009 8:56 am

As Jane Hamsher noted today, Marcy Winograd, the progressive challenger to Jane Harman in CA-36, released a letter savaging Harman for her support of the Eshoo amendment on biologics in the Energy and Commerce Committee. Though Congressman Waxman (D-Santa Monica/West LA) had introduced an amendment for a 5-year fast-track of generic biologics, Harman joined with [...]

The Disaster That Is The GOP Health Care Bill

By: Tuesday November 3, 2009 12:34 pm

You knew that the Republican health care bill, which leaked out today, was going to be bad when the Wall Street Journal scrubbed an article critical of it from their website. (There’s still a screen cap of the story floating out there.) Seeing the actual draft bill does not improve matters for the GOP. As [...]

Sherrod Brown: Biologics Should Not Be Subject To An “Endless Monopoly Period”

By: Monday November 2, 2009 2:56 pm

Sen. Sherrod Brown of Ohio has been the leading voice in the Senate on the issue of biologics, the expensive drug treatments made from living organisms, and his advocacy for affordable, generic versions of the potentially life-saving drugs will continue once the Senate health care bill hits the floor. The Senate HELP Committee version of [...]

Fight To Blow Up The Big Pharma Deal Includes Biologics Patents

By: Sunday November 1, 2009 5:52 pm

The health care bill from the House of Representatives adds $14 billion dollars to the negotiated “deal” between the pharmaceutical industry and the White House, forcing PhRMa to pony up that much more than the $80 billion to which they agreed. Nancy Pelosi described it as because of the Blue Dogs forcing negotiated rates for [...]

support firedoglake
Follow FDL News Desk
TODAY’S TOP POSTS
Advertisement
FROM PR NEWSWIRE

Close